Up to $287 million Series D1 backs CORXEL’s bi
Author: Michael
Alterity Therapeutics Ltd.
Life Time Group Holdings, Inc., the U.S.
BioAge Labs, Inc.
Hundred Health founder on why building the ‘de
Pooled MRI and memory data from thousands of adu
L-Nutra to establish manufacturing center in Abu
Beauty is moving beyond ‘antiaging’ toward p
Amycretin enters phase III trials, promising fas
Insilico Medicine and Hygtia Therapeutics have en